Loading...
This week's FierceLifeSci is brought to you by ExL Events. |
Dear Reader, I am pleased to invite you to the third annual FierceBiotech Drug Development Forum (DDF). This year's conference is taking place in Boston, October 1–3, 2018 and is still the only event that covers the entire drug development process from basic research through clinical trials. Registration is available by clicking here. Our all-new program features managing VC relationships, beating ambitious growth plans, developing your immuno-oncology business model, adapting to new regulatory and pricing realities — and much more. See below for a sample of some of our program panels and click here to view the full program. Innovate Value-Based Pricing Models for Long-Lasting Therapies Fine-Tune Biotech Priorities for Improving Diversity Combination Therapies for Immuno-Oncology Nurturing Relationships with VCs and Planning Financial Strategy Manage Partnerships and Portfolios to Survive the Next Market Downturn Specialize your CRO Outreach for Early Research Improve your Orphan Drug Strategy for GrowthAnd here are just a few of our confirmed speakers. Click here to view our full list of speakers. Andrew Allen, CEO, Gritstone Oncology Stephen Bancel, CEO, Moderna Therapeutics Roy Baynes, CMO, VP, Head of Clinical Development, Merck Barbara Dalton, VP, Venture Capital, Pfizer Robert Gould, CEO, Fulcrum Therapeutics Douglas Ingram, CEO, Sarepta Therapeutics Salim Mujais, Senior VP, Global Therapeutics Head, Specialty Pharma, Astellas Chandra Ramanathan, VP and Head, East Coast Innovation Center, Bayer Amrit Ray, Global President, R&D, PFIZER Martine Zimmerman, Senior VP, Global Regulatory Affairs, Alexion PharmaceuticalsDon't miss this chance to attend this year's conference. I look forward to seeing you in Boston. Early bird rates expire August 17 so be sure to register soon. Regards, Rebecca Willumson —Sponsorship opportunities are still available. If you are interested in sponsoring DDF, please email Andrew Sinetar at asinetar@exlevents.com. |
Want to reach 160,000+ FierceBiotech subscribers with your own message?
FierceMarkets 1900 L St. NW Suite we 400 Washington, DC 20036 |
Loading...
Loading...